With fo­cus on ne­glect­ed eye dis­eases, Opus buys two gene ther­a­pies from Iver­ic Bio

A seed-stage biotech found­ed by Lux­tur­na’s in­ven­tor has ac­quired two gene ther­a­py prod­ucts from a biotech that just sub­mit­ted an NDA.

Opus Ge­net­ics paid Iver­ic …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER